- Home
- CNSP vs BMRA Comparison
CNSP vs BMRA Comparison
Compare CNSP & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- BMRA
- Stock Information
- Founded
- CNSP 2017
- BMRA 1971
- Country
- CNSP United States
- BMRA United States
- Employees
- CNSP N/A
- BMRA N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CNSP Health Care
- BMRA Health Care
- Exchange
- CNSP Nasdaq
- BMRA Nasdaq
- Market Cap
- CNSP 6.5M
- BMRA 5.9M
- IPO Year
- CNSP 2019
- BMRA N/A
- Fundamental
- Price
- CNSP $0.10
- BMRA $0.43
- Analyst Decision
- CNSP Strong Buy
- BMRA
- Analyst Count
- CNSP 1
- BMRA 0
- Target Price
- CNSP $0.50
- BMRA N/A
- AVG Volume (30 Days)
- CNSP 29.2M
- BMRA 21.2M
- Earning Date
- CNSP 03-31-2025
- BMRA 01-14-2025
- Dividend Yield
- CNSP N/A
- BMRA N/A
- EPS Growth
- CNSP N/A
- BMRA N/A
- EPS
- CNSP N/A
- BMRA N/A
- Revenue
- CNSP N/A
- BMRA $5,578,000.00
- Revenue This Year
- CNSP N/A
- BMRA N/A
- Revenue Next Year
- CNSP N/A
- BMRA N/A
- P/E Ratio
- CNSP N/A
- BMRA N/A
- Revenue Growth
- CNSP N/A
- BMRA 1.40
- 52 Week Low
- CNSP $0.08
- BMRA $0.24
- 52 Week High
- CNSP $23.90
- BMRA $1.35
- Technical
- Relative Strength Index (RSI)
- CNSP 41.60
- BMRA 48.88
- Support Level
- CNSP $0.09
- BMRA $0.53
- Resistance Level
- CNSP $0.10
- BMRA $0.72
- Average True Range (ATR)
- CNSP 0.01
- BMRA 0.13
- MACD
- CNSP -0.00
- BMRA -0.01
- Stochastic Oscillator
- CNSP 43.33
- BMRA 15.84
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.